Cargando…
Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction
OBJECTIVE: Chronic heart failure with reduced ejection fraction (HF-REF) represents a major public health issue and is associated with considerable morbidity and mortality. We evaluated the cost-effectiveness of sacubitril/valsartan (formerly LCZ696) compared with an ACE inhibitor (ACEI) (enalapril)...
Autores principales: | McMurray, John J V, Trueman, David, Hancock, Elizabeth, Cowie, Martin R, Briggs, Andrew, Taylor, Matthew, Mumby-Croft, Juliet, Woodcock, Fionn, Lacey, Michael, Haroun, Rola, Deschaseaux, Celine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992367/ https://www.ncbi.nlm.nih.gov/pubmed/29269379 http://dx.doi.org/10.1136/heartjnl-2016-310661 |
Ejemplares similares
-
A cardiovascular disease policy model: part 2—preparing for economic evaluation and to assess health inequalities
por: Lawson, K D, et al.
Publicado: (2016) -
Reducing patient delay with symptoms of acute coronary syndrome: a research protocol for a systematic review of previous interventions to investigate which behaviour change techniques are associated with effective interventions
por: Farquharson, Barbara, et al.
Publicado: (2014) -
Transfer of residents to hospital prior to cardiac death: the influence of nursing home quality and ownership type
por: Anic, Gabriella M, et al.
Publicado: (2014) -
Identifying barriers to participation in cardiac prevention and rehabilitation programmes via decision tree analysis: establishing targets for remedial interventions
por: Reges, Orna, et al.
Publicado: (2014) -
The reduced cost of providing a nationally recognised service for familial hypercholesterolaemia
por: Pears, Robert, et al.
Publicado: (2014)